{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:26:31Z","timestamp":1791246391976,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/22572-9"],"award-info":[{"award-number":["2014\/22572-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/07117-9"],"award-info":[{"award-number":["2016\/07117-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12072-022-10366-z","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T15:09:09Z","timestamp":1656515349000},"page":"1458-1467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial"],"prefix":"10.1007","volume":"16","author":[{"given":"L\u00edvia Alves Amaral","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talles Bazeia","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio Rubens","family":"de Carvalho Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingshun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-6895","authenticated-orcid":false,"given":"Fernando Gomes","family":"Romeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"3","key":"10366_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/00365521.2020.1735507","volume":"55","author":"E Huld\u00e9n","year":"2020","unstructured":"Huld\u00e9n E, Castedal M, Karlsson MK, Kalaitzakis E, Sw\u00e4rd P. Osteoporosis in cirrhotics before and after liver transplantation: relation with malnutrition and inflammatory status. Scand J Gastroenterol 2020;55(3):354\u2013361. https:\/\/doi.org\/10.1080\/00365521.2020.1735507","journal-title":"Scand J Gastroenterol"},{"issue":"17","key":"10366_CR2","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.3390\/ijms20174270","volume":"20","author":"HM Jeong","year":"2019","unstructured":"Jeong HM, Kim DJ. Bone diseases in patients with chronic liver disease. Int J Mol Sci 2019;20(17):4270. https:\/\/doi.org\/10.3390\/ijms20174270","journal-title":"Int J Mol Sci"},{"key":"10366_CR3","doi-asserted-by":"publisher","first-page":"1423462","DOI":"10.1155\/2016\/1423462","volume":"2016","author":"LA Santos","year":"2016","unstructured":"Santos LA, Romeiro FG. Diagnosis and management of cirrhosis-related osteoporosis. Biomed Res Int 2016;2016:1423462. https:\/\/doi.org\/10.1155\/2016\/1423462","journal-title":"Biomed Res Int"},{"issue":"1","key":"10366_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2019;30(1):3\u201344. https:\/\/doi.org\/10.1007\/s00198-018-4704-5","journal-title":"Osteoporos Int."},{"issue":"Suppl 1","key":"10366_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 2020;26(Suppl 1):1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"issue":"1","key":"10366_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2050640615584535","volume":"4","author":"RK Bansal","year":"2016","unstructured":"Bansal RK, Kumar M, Sachdeva PR, Kumar A. Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact o. United European Gastroenterol J 2016;4(1):77\u201383. https:\/\/doi.org\/10.1177\/2050640615584535","journal-title":"United European Gastroenterol J."},{"issue":"1","key":"10366_CR7","doi-asserted-by":"publisher","first-page":"18958","DOI":"10.1038\/s41598-019-55603-y","volume":"9","author":"TB Lima","year":"2019","unstructured":"Lima TB, Santos LAA, Nunes HRC, Silva GF, Caramori CA, Qi X, et al. Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial. Sci Rep 2019;9(1):18958. https:\/\/doi.org\/10.1038\/s41598-019-55603-y","journal-title":"Sci Rep"},{"issue":"7","key":"10366_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00198-014-2703-8","volume":"25","author":"C Senn","year":"2014","unstructured":"Senn C, G\u00fcnther B, Popp AW, Perrelet R, Hans D, Lippuner K. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Osteoporos Int 2014;25(7):1945\u20131951. https:\/\/doi.org\/10.1007\/s00198-014-2703-8","journal-title":"Osteoporos Int"},{"key":"10366_CR9","doi-asserted-by":"publisher","unstructured":"McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344(5):333\u201340. https:\/\/doi.org\/10.1056\/NEJM200102013440503","DOI":"10.1056\/NEJM200102013440503"},{"key":"10366_CR10","doi-asserted-by":"publisher","unstructured":"McClung MR, Zanchetta JR, Racewicz A, Roux C, Benhamou CL, Man Z, et al. Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. Osteoporos Int 2013;24(1):293\u20139. https:\/\/doi.org\/10.1007\/s00198-012-2056-0","DOI":"10.1007\/s00198-012-2056-0"},{"key":"10366_CR11","doi-asserted-by":"publisher","unstructured":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000;11(1):83\u201391. https:\/\/doi.org\/10.1007\/s001980050010","DOI":"10.1007\/s001980050010"},{"issue":"1","key":"10366_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11926-996-0070-y","volume":"2","author":"JA Kanis","year":"2000","unstructured":"Kanis JA. An update on the diagnosis of osteoporosis. Curr Rheumatol Rep 2000;2(1):62\u201366. https:\/\/doi.org\/10.1007\/s11926-996-0070-y","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"10366_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9(8):1137\u20131141. https:\/\/doi.org\/10.1002\/jbmr.5650090802","journal-title":"J Bone Miner Res"},{"key":"10366_CR14","doi-asserted-by":"publisher","unstructured":"Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, Kokudo N,et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 2010;22(1):1\u20139. https:\/\/doi.org\/10.1111\/j.1443-1661.2009.00929.x","DOI":"10.1111\/j.1443-1661.2009.00929.x"},{"issue":"2","key":"10366_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gut.45.2.172","volume":"45","author":"LR Lundell","year":"1999","unstructured":"Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45(2):172\u2013180. https:\/\/doi.org\/10.1136\/gut.45.2.172","journal-title":"Gut"},{"key":"10366_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0300-5089(21)00034-1","volume":"2","author":"T Sakita","year":"1973","unstructured":"Sakita T. Endoscopy in diagnosis of early gastric cancer. Clin Gastroenterol 1973;2:345\u2013360","journal-title":"Clin Gastroenterol"},{"issue":"11","key":"10366_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/gut.26.11.1226","volume":"26","author":"TT McCormack","year":"1985","unstructured":"McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, et al. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26(11):1226\u20131232. https:\/\/doi.org\/10.1136\/gut.26.11.1226","journal-title":"Gut"},{"key":"10366_CR18","doi-asserted-by":"publisher","unstructured":"Yamamoto K, Kishino M, Nakamura S, Tokushige K. Symptoms and upper gastrointestinal mucosal injury associated with bisphosphonate therapy. Intern Med 2019;58(8):1049\u20131056. https:\/\/doi.org\/10.2169\/internalmedicine.1271-18","DOI":"10.2169\/internalmedicine.1271-18"},{"issue":"1","key":"10366_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-012-2213-5","volume":"24","author":"JH Kang","year":"2013","unstructured":"Kang JH, Keller JJ, Lin HC. Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study. Osteoporos Int 2013;24(1):271\u2013277. https:\/\/doi.org\/10.1007\/s00198-012-2213-5","journal-title":"Osteoporos Int"},{"issue":"10","key":"10366_CR20","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00198-012-1894-0","volume":"23","author":"JH Kang","year":"2012","unstructured":"Kang JH, Keller JJ, Lin HC. A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke. Osteoporos Int 2012;23(10):2551\u20132557. https:\/\/doi.org\/10.1007\/s00198-012-1894-0","journal-title":"Osteoporos Int"},{"key":"10366_CR21","doi-asserted-by":"publisher","unstructured":"Peris P, Par\u00e9s A, Gua\u00f1abens N, Del R\u00edo L, Pons F, Mart\u00ednez de Osaba MJ, Monegal A, et al. Bone mass improves in alcoholics after 2 years of abstinence. J Bone Miner Res 1994;9(10):1607\u201312. https:\/\/doi.org\/10.1002\/jbmr.5650091014.","DOI":"10.1002\/jbmr.5650091014"},{"issue":"1","key":"10366_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-011-1787-7","volume":"23","author":"DB Maurel","year":"2012","unstructured":"Maurel DB, Boisseau N, Benhamou CL, Jaffre C. Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int 2012;23(1):1\u201316. https:\/\/doi.org\/10.1007\/s00198-011-1787-7","journal-title":"Osteoporos Int"},{"issue":"9","key":"10366_CR23","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/jgh.15007","volume":"35","author":"TC Yip","year":"2020","unstructured":"Yip TC, Lee HW, Wong VW, Wong GL, Tse YK, Lui GC, et al. Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B. J Gastroenterol Hepatol 2020;35(9):1610\u20131618. https:\/\/doi.org\/10.1111\/jgh.15007","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10366_CR24","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jhep.2017.08.008","volume":"67","author":"JM Pascasio","year":"2017","unstructured":"Pascasio JM, Vinaixa C, Ferrer MT, Colmenero J, Rubin A, Castells L, et al. Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation. J Hepatol 2017;67(6):1168\u20131176. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.008","journal-title":"J Hepatol"},{"key":"10366_CR25","doi-asserted-by":"publisher","unstructured":"Belli LS, Berenguer M, Cortesi PA, Strazzabosco M, Rockenschaub SR, Martini S, Morelli C, et al.. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study. J Hepatol 2016;65(3):524\u201331. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.010","DOI":"10.1016\/j.jhep.2016.05.010"},{"issue":"11","key":"10366_CR26","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/tri.13008","volume":"30","author":"AD Aravinthan","year":"2017","unstructured":"Aravinthan AD, Barbas AS, Doyle AC, Tazari M, Sapisochin G, Cattral MS, et al. Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case\u2013control study. Transpl Int 2017;30(11):1140\u20131149. https:\/\/doi.org\/10.1111\/tri.13008","journal-title":"Transpl Int"},{"issue":"4","key":"10366_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1572-0241.1999.984_g.x","volume":"94","author":"A Zaman","year":"1999","unstructured":"Zaman A, Hapke R, Flora K, Rosen H, Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol 1999;94(4):895\u2013899. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.984_g.x","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"10366_CR28","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3748\/wjg.v17.i13.1753","volume":"17","author":"J Zhang","year":"2011","unstructured":"Zhang J, Cui PL, Lv D, Yao SW, Xu YQ, Yang ZX. Gastroesophageal reflux in cirrhotic patients without esophageal varices. World J Gastroenterol 2011;17(13):1753\u20131758. https:\/\/doi.org\/10.3748\/wjg.v17.i13.1753","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10366_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jebm.12407","volume":"13","author":"DV Garbuzenko","year":"2020","unstructured":"Garbuzenko DV, Arefyev NO. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: an update and review of the literature. J Evid Based Med 2020;13(4):313\u2013324. https:\/\/doi.org\/10.1111\/jebm.12407","journal-title":"J Evid Based Med"},{"issue":"3","key":"10366_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Faculty BVI. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63(3):743\u2013752. https:\/\/doi.org\/10.1016\/j.jhep.2015.05.022","journal-title":"J Hepatol"},{"issue":"5","key":"10366_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/apt.13061","volume":"41","author":"G Dultz","year":"2015","unstructured":"Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Aliment Pharmacol Ther 2015;41(5):459\u2013466. https:\/\/doi.org\/10.1111\/apt.13061","journal-title":"Aliment Pharmacol Ther"},{"issue":"11\u201312","key":"10366_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/apt.13827","volume":"44","author":"HL Cole","year":"2016","unstructured":"Cole HL, Pennycook S, Hayes PC. The impact of proton pump inhibitor therapy on patients with liver disease. Aliment Pharmacol Ther 2016;44(11\u201312):1213\u20131223. https:\/\/doi.org\/10.1111\/apt.13827","journal-title":"Aliment Pharmacol Ther"},{"key":"10366_CR33","doi-asserted-by":"publisher","unstructured":"Kishimoto H, Maehara M. Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA. Arch Osteoporos 2015;10:231. https:\/\/doi.org\/10.1007\/s11657-015-0231-6.","DOI":"10.1007\/s11657-015-0231-6"},{"issue":"2","key":"10366_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/00952990.2014.964358","volume":"41","author":"PK Mankal","year":"2015","unstructured":"Mankal PK, Abed J, Aristy JD, Munot K, Suneja U, Engelson ES, et al. Relative effects of heavy alcohol use and hepatitis C in decompensated chronic liver disease in a hospital inpatient population. Am J Drug Alcohol Abuse 2015;41(2):177\u2013182. https:\/\/doi.org\/10.3109\/00952990.2014.964358","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10366_CR35","doi-asserted-by":"publisher","unstructured":"Bassegoda O, Olivas P, Turco L, Mandorfer M, Serra-Burriel M, Tellez L, Kwanten W, et al.. Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease. Clin Gastroenterol Hepatol 2021. https:\/\/doi.org\/10.1016\/j.cgh.2021.10.023","DOI":"10.1016\/j.cgh.2021.10.023"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10366-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10366-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10366-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:38:55Z","timestamp":1669513135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10366-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10366"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10366-z","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L\u00edvia Alves Amaral Santos, Talles Bazeia Lima, H\u00e9lio Rubens de Carvalho Nunes, Xingshun Qi and Fernando Gomes Romeiro declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (denoted \u201cComit\u00ea de \u00c9tica em Pesquisa\u201d - protocol number 089211-2013) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The project was registered in a publicly accessible primary International Clinical Trial Registry Platform (named REBEC clinical trials platform, available at ), where the registration date and the trial registration number were 10\/11\/2015 and RBR-76pm35, respectively.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials registration"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}